To read the full version of this content please select one of the options below:

Roche and Tamiflu®: Doing Business in the Shadow of Pandemic

Kellogg School of Management Cases

ISSN: 2474-6568

Publication date: 20 January 2017

Abstract

Students will weigh the benefits of short-term profit maximization against the risks that a highly uncertain event could pose to a business and consider nonstandard approaches to mitigate these risks. Students will discuss the challenges of addressing low-probability, high-impact events; potential conflicts with the short-term view of the stock market and analyst community; and challenges of the patent protection model for drugs for life-threatening diseases.

Keywords

Citation

Feddersen, T., Gottschalk, J. and Peters, L. (2017), "Roche and Tamiflu®: Doing Business in the Shadow of Pandemic", Kellogg School of Management Cases. https://doi.org/10.1108/case.kellogg.2016.000286

Publisher

:

Kellogg School of Management

Copyright © 2007, The Kellogg School of Management at Northwestern University